Chicarelli, M., Crow, M., Alley, K., Bettendorf, T., Blandon, A., Born, A., Brizendine, R., Carlson, P., Chatterjee, P., Fell, B., Fischer, J., Fulton, J., Guarnieri, A., Jalluri, R., Johnson, A., Koch, K., Kumar, V., Malinky, C., McDonald, M., Mchugh, C., McVean, M., Newhouse, B., Niman, S., Rieger, R., Robinson, J., Rodriguez, M., Salituro, L., Salvo, P., Sullivan, F., Trujillo, J., Venteicher, B., Vine, L., Winski, S., Work, H., Zhou, Y. (2025). Preclinical characterization of a novel, wild-type-sparing, JAK2 V617F mutant-selective inhibitor. Blood. https://doi.org/10.1182/blood-2025-3752